Published in Biull Eksp Biol Med on October 01, 1981
[Intravital estimation of doxorubicin accumulation in various types of cell cultures]. Antibiot Khimioter (1990) 1.02
[Estrogen receptor expression in tumors different from breast cancer]. Antibiot Khimioter (2009) 0.86
Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice. Cancer Treat Rep (1976) 0.83
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol (1999) 0.81
[Neutron activation analysis in the pharmacokinetics of cis-dichlorodiammineplatinum (experimental studies)]. Med Radiol (Mosk) (1980) 0.81
[ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs]. Antibiot Khimioter (2015) 0.81
[Expression of estrogen receptors beta and beta1 in tissue of human non-small cell lung cancer]. Antibiot Khimioter (2012) 0.81
[Protective activity of secreted proteins of Streptococcus pneumoniae and Klebsiella pneumoniae]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.80
[Protease activity of Klebsiella pneumoniae of different virulence]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.77
[Functional activity of ABC transporters (markers of multidrug resistance) in human colon adenocarcinoma and normal colonic mucosa]. Antibiot Khimioter (2002) 0.77
A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer. Dokl Biochem Biophys (2007) 0.76
[Associated synthesis of some secreted pathogenicity factors of Klebsiella pneumoniae]. Vestn Ross Akad Med Nauk (2005) 0.76
Destructive effect of DNA topoisomerase II inhibitor vepesid on mouse spermatogenesis. Bull Exp Biol Med (2003) 0.76
Damaging effect of taxol on mouse spermatogenesis. Bull Exp Biol Med (2001) 0.76
Influence of Fucoidans and Their Derivatives on Antitumor and Phagocytic Activity of Human Blood Leucocytes. Biochemistry (Mosc) (2015) 0.76
[The virucidal properties of neoaquasept]. Eksp Klin Farmakol (1993) 0.76
[The cytotoxicity of Chamaenerium angustifolium (L.) Scop. and Hippophae rhamnoides L. tannins and their effect on mitochondrial respiration]. Eksp Klin Farmakol (1997) 0.75
[The biochemical mechanisms of the action of N-alkyl-N-nitrosoureas. The possible reasons for drug resistance to these compounds]. Eksp Klin Farmakol (1996) 0.75
[Enhancement of antineoplastic activity of sarcolysin by the means of transforming it into lipid derivative and incorporating into liposomal membranes containing carbohydrate vector]. Biull Eksp Biol Med (1997) 0.75
[The effect of different antitumor preparations on the growth of a culture of the protozoan Crithidia oncopelti]. Izv Akad Nauk SSSR Biol (1989) 0.75
[Effect of chloramphenicol on the toxic and therapeutic effect of N-nitrosomethylurea]. Vopr Onkol (1977) 0.75
[Effect of calcium gluconate on the toxicity and antitumor of doxorubicin in mice]. Antibiot Khimioter (1999) 0.75
[Influence of ABC-transporters on intracellular distribution of anticancer drugs and contribution of this index to multidrug resistance phenotype]. Antibiot Khimioter (2005) 0.75
[Comparative study of the effect of zixoryn and phenobarbital on the toxicity of anthracycline antibiotics and liver monooxygenase activity in mice]. Vestn Akad Med Nauk SSSR (1985) 0.75
[Effect of chloramphenicol on binding of H3-dimethylbenz-(alpha)-anthracene with nucleic acids in normal mouse embryonic cell cultures]. Dokl Akad Nauk SSSR (1973) 0.75
[Potentiation by blastolysin of the effect of cyclophosphamide in preventing recurrence in mouse T-cell leukemia]. Biull Eksp Biol Med (1984) 0.75
[Dextran-ferrite distribution in the body of animals in a nonuniform permanent magnetic field]. Eksp Onkol (1990) 0.75
[Mitigation of cisplatin toxicity by the complexon tetacin-calcium]. Eksp Onkol (1985) 0.75
[The preclinical assessment of the activity and pharmacological action of native human interleukin-2]. Patol Fiziol Eksp Ter (1990) 0.75
[Hepatotoxic effects of drugs from some pharmacological groups]. Klin Med (Mosk) (2003) 0.75
[Lifetime quantitative assessment of intracellular distribution of doxorubicin in tumor cells]. Biull Eksp Biol Med (1995) 0.75
[Use of Hoechst fluorescent probe 33258 for quantitative analysis of intracellular binding of anthracycline antibiotics to DNA]. Antibiot Khimioter (1992) 0.75
On the influence of chloramphenicol on the induction of lung adenomas by urethane in mice. Neoplasma (1975) 0.75
[Toxicological properties of fentirin]. Farmakol Toksikol (1980) 0.75
[Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice with Ehrlich ascites cancer]. Eksp Onkol (1985) 0.75
[Effect of unithiol and thymidine on the toxic and therapeutic action of adriamycin]. Vopr Onkol (1986) 0.75
[The pharmacological strategy of overcoming the phenotype of the multiple pharmacoresistance of non-small-cell lung cancer]. Vestn Ross Akad Med Nauk (2007) 0.75
[Changes in the activity of nonspecific liver oxidases after surgery for cancer in children]. Pediatriia (1982) 0.75
[Reducing of hepatotoxicity of antineoplastic chemotherapy and concomitant viral infection through control of liver metabolism: from experiment to clinical practice]. Vopr Onkol (2001) 0.75
[Decreasing the toxicity of antitumor preparations--the way to enhancing treatment efficacy in malignant tumors]. Vopr Onkol (1995) 0.75
[Radiobiological analysis of the antineoplastic action of sarcolysine]. Med Radiol (Mosk) (1982) 0.75
[The trypanocidal action of fluorouracil on Crithidia oncopelti in the presence of lipid metabolic modifiers]. Izv Akad Nauk SSSR Biol (1992) 0.75
[The drop in toxicity and the rise in the effectiveness of antineoplastic chemotherapy by correcting the activity of liver monooxygenases: from the experiment to the clinical practice]. Vestn Ross Akad Med Nauk (2002) 0.75
[Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Antineoplastic and toxic effects of blastolysin in the treatment of spontaneous mammary cancer in dogs]. Eksp Onkol (1984) 0.75
The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521). Arzneimittelforschung (1977) 0.75
[The rate of antipyrine metabolism in cancer patients administered specific therapy]. Vopr Onkol (1992) 0.75
[Activity of hepatic nonspecific oxidases and the biological effects of antitumor preparations]. Vestn Akad Med Nauk SSSR (1981) 0.75
[The experimental chemotherapy of malignant tumors today]. Vopr Onkol (1995) 0.75
[Parameters of specific antibody interaction with P-gp in T-cell leukemia Jurkat cells]. Antibiot Khimioter (2009) 0.75
Design of cancer chemotherapy: tailored sensitivity assays. Antibiot Chemother (1971) (1980) 0.75
[Synaptonemal complexes of chromosomes of male mice after prolonged administration of neoaquasept]. Genetika (1993) 0.75
Effect of chloramphenicol and dextramycine on the toxicity of carcinogenic hydrocarbons. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1974) 0.75
[Intensive intraperitoneal growth of human melanoma in immunocompetent mice following whole-body irradiation]. Vestn Akad Med Nauk SSSR (1988) 0.75
Preclinical study of antitumor compounds. Natl Cancer Inst Monogr (1977) 0.75
Dextramycine (the dextraisomer of chloramphenicol) as an inhibitor of the induction of lung adenomas in mice. Neoplasma (1977) 0.75
[Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin]. Antibiotiki (1984) 0.75
[Intracellular accumulation of free doxorubicin and doxorubicin encapsulated in nanospheres]. Biull Eksp Biol Med (1994) 0.75
[ICO-166 monoclonal antibodies against the CD45RA antigen]. Biull Eksp Biol Med (1993) 0.75
[Effect of the induction and inhibition of liver monooxygenases on the toxic and therapeutic action of vincristine]. Antibiot Med Biotekhnol (1986) 0.75
[Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors]. Vopr Onkol (1990) 0.75
[Effect of chloramphenicol on the toxic action of 7,12-dimethylbenz-alpha-anthracene in a culture of embryonic fibroblasts]. Tsitologiia (1971) 0.75
[Quantitative determination of anthracycline antibiotic binding with DNA]. Biull Eksp Biol Med (1992) 0.75
[Development of substances for active prevention of cancer based on vitamins and preventive-treatment products]. Vopr Med Khim (1993) 0.75
[Blastolysin, an agent potentiating the antitumor action of ionizing radiation]. Dokl Akad Nauk SSSR (1980) 0.75
[Antitumor and toxic effects of amotin]. Eksp Onkol (1987) 0.75
[Development of oncological research performed at the dissertation level 1976-1980]. Vopr Onkol (1983) 0.75
[Lowering of adriamycin toxicity by its combined administration with a copper Cu-2 complex]. Biull Eksp Biol Med (1989) 0.75
[The effect of topoisomerase II inhibitor, vepesid, on binding of doxorubicin with DNA in tumor cells sensitive to anthracycline]. Biull Eksp Biol Med (1997) 0.75
[The effect of chloramphenicol on the toxic action of benz(alpha)pyrene in a culture of embryonic mouse cells]. Vopr Onkol (1972) 0.75
[Tamoxifen molecular targets different from estrogen receptors]. Antibiot Khimioter (2012) 0.75
[Effect of MESNA on intracellular accumulation of doxorubicin and its interaction with DNA]. Antibiot Khimioter (1995) 0.75
[Effect of chloramphenicol on the activity of nonspecific rat liver oxidases]. Dokl Akad Nauk SSSR (1978) 0.75
[Analysis of dissertations on antineoplastic chemotherapy presented 1981-1985]. Vopr Onkol (1988) 0.75
[Antidotal and antineoplastic properties of copper sulfate]. Biull Eksp Biol Med (1988) 0.75
[Effect of chloramphenicol on the toxic and therapeutic actions of cyclophosphane]. Antibiot Med Biotekhnol (1986) 0.75
[Effect of chloramphenicol on the blastomogenic effect of N-nitrosomethylurea]. Biull Eksp Biol Med (1978) 0.75
[Protective effect of chloramphenicol and dextramycin following the adrenocorticolytic action of 7, 12-dimethylbenz(a)anthracene]. Biull Eksp Biol Med (1977) 0.75
Effect of chloramphenicol on the metabolism of carcinogenic hydrocarbons and binding to cellular macromolecules. Arzneimittelforschung (1974) 0.75
[Glutoxime--an inhibitor of multiple drug resistance phenotype associated with Pgp expression]. Antibiot Khimioter (2010) 0.75
Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs. Oncology (1980) 0.75
[Interaction of the complex copper compound Cu-2 with liver monooxygenases]. Biull Eksp Biol Med (1987) 0.75
[Chloramphenicol and dextramycin, inhibitors of mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene]. Biull Eksp Biol Med (1979) 0.75
[Effect of dextramycin on the toxic effects of DMBA and its derivatives]. Vopr Onkol (1974) 0.75
[Discordance of estrogen receptor status between primary and metastatic breast cancer--possible reasons and prognostic value]. Antibiot Khimioter (2013) 0.75
[The induction of tolerance in mice for a human melanoma graft]. Eksp Onkol (1990) 0.75
[Estrogen receptors beta--new target in cellular lung cancer treatment]. Vestn Ross Akad Med Nauk (2012) 0.75
[New concepts of microsomal metabolism of the antibiotic adriamycin]. Bioorg Khim (1985) 0.75
[The effect of calcium gluconate on the acute and chronic toxicity of doxorubicin in mice]. Antibiot Khimioter (1997) 0.75